SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-16-088155
Filing Date
2016-03-15
Accepted
2016-03-15 16:01:25
Documents
68
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v432524_10k.htm 10-K 956751
2 EXHIBIT 23.1 v432524_ex23-1.htm EX-23.1 2407
3 EXHIBIT 31.1 v432524_ex31-1.htm EX-31.1 10770
4 EXHIBIT 31.2 v432524_ex31-2.htm EX-31.2 10669
5 EXHIBIT 32.1 v432524_ex32-1.htm EX-32.1 3501
6 EXHIBIT 32.2 v432524_ex32-2.htm EX-32.2 3356
7 GRAPHIC tpg10.jpg GRAPHIC 30885
8 GRAPHIC tpg39.jpg GRAPHIC 73420
  Complete submission text file 0001144204-16-088155.txt   5876542

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT tgtx-20151231.xml EX-101.INS 1253907
10 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20151231.xsd EX-101.SCH 59724
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20151231_cal.xml EX-101.CAL 48560
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20151231_def.xml EX-101.DEF 309133
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20151231_lab.xml EX-101.LAB 410873
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20151231_pre.xml EX-101.PRE 357232
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32639 | Film No.: 161506873
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences